UGT2B17 and B-cell chronic lymphocytic leukemia: Although we could show that UGT2B17 is expressed in normal B-cells, its higher expression in B-CLL patients’ cells, and further enhanced in CLL cases with poor prognosis, may involve such a mechanism.